Home > Cancer Care > Clinical Research Trials > Clinical Trials Details
Back to Results
This phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia who have not received previous treatment.
NCT#03737981